Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
43 participants
OBSERVATIONAL
2020-06-27
2021-09-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab.
Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine.
A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer. The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind.
The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.
NCT04388631
Semen Analysis Changes in Covid-19 Positivepatients
NCT04595240
Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients
NCT04717011
Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ?
NCT04487639
Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters
NCT04937608
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab.
Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine.
A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer.
According to results obtained, follow up will be tailored to patients (assessment for COVID 19 infections and/or further analysis/folliow-up in case of abnormal findings) The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind.
The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SARS-CoV 2 Patients
Patients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
SARS-CoV 2 RNA PCR Urine
Search for SARS-CoV 2 RNA in urine through PCR
SARS-CoV 2 RNA PCR Semen
Search for SARS-CoV 2 RNA in Semen through PCR
Semen Qualitative Analysis
Search for Semen Alterations in patients with past SARS-CoV 2 infection
IIEF-5 questionnaire
IIEF-5 assessment in patients with past SARS-CoV 2 infection
Male Sexual Health Questionnaire (MSHQ)
Male Sexual Health Questionnaire (MSHQ) assessment in patients with past SARS-CoV 2 infection
IPSS questionnaire
IPSS assessment in patients with past SARS-CoV 2 infection
SECRET questionnaire
SECRET questionnaire assessment in patients with past SARS-CoV 2 infection
Interleukin assessment in semen
Assessment of Interleukin presence and quantitative analysis in semen, to study if a previous inflammation/infection due to SARS-CoV 2 in testis was present
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SARS-CoV 2 RNA PCR Urine
Search for SARS-CoV 2 RNA in urine through PCR
SARS-CoV 2 RNA PCR Semen
Search for SARS-CoV 2 RNA in Semen through PCR
Semen Qualitative Analysis
Search for Semen Alterations in patients with past SARS-CoV 2 infection
IIEF-5 questionnaire
IIEF-5 assessment in patients with past SARS-CoV 2 infection
Male Sexual Health Questionnaire (MSHQ)
Male Sexual Health Questionnaire (MSHQ) assessment in patients with past SARS-CoV 2 infection
IPSS questionnaire
IPSS assessment in patients with past SARS-CoV 2 infection
SECRET questionnaire
SECRET questionnaire assessment in patients with past SARS-CoV 2 infection
Interleukin assessment in semen
Assessment of Interleukin presence and quantitative analysis in semen, to study if a previous inflammation/infection due to SARS-CoV 2 in testis was present
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age\>18 years
* Will to participate to the study
* Documented past infection for SARS-CoV2 (Nasopharyngeal swab positive for SARS-CoV2 RNA)
* Current negative infection for SARS-CoV2 (Two negative Nasopharyngeal swab for SARS-CoV2 RNA, done following WHO guidelines)
Exclusion Criteria
* Anejaculation
* Patient's will
18 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliero-Universitaria Careggi
OTHER
University of Florence
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simone Morselli
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mauro Gacci, MD
Role: PRINCIPAL_INVESTIGATOR
Careggi University Hospital
Sergio Serni, Prof
Role: STUDY_DIRECTOR
University of Florence
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AOU Careggi
Florence, Tuscany, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17104_oss/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.